Many cancer drugs remain unproven 5 years after accelerated approval, a study finds – The Associated Press
Business News
- Many cancer drugs remain unproven 5 years after accelerated approval, a study finds The Associated Press
- Half of cancer drugs given accelerated approval fail in later trials – STAT STAT
- Speedier drug approvals hit slowdown as FDA faces scrutiny The Associated Press
- Study: Many cancer drugs remain unproven 5 years after accelerated approval Pittsburgh Post-Gazette
- Scripps News-ProPublica investigation sparks Michigan cancer drug bill Scripps News
Source: Business News